0      0

AM23-TU-03-O - AM23-TU-03-O: Biotherapies Abstract Spotlight (Enduring)

Expiration Date: Dec 31, 2025

Credits: None available.

Dr. Donald Siegel will address the most current advances and trends in biotherapies research followed by four biotherapies related oral abstracts and a question-and-answer period.




  • Don Siegel, MD, PhD:
    Verismo Therapeutics: Consultant/Advisory Board (Ongoing), Founder (Ongoing), Grant/Research Support (Ongoing), Stock Shareholder (self-managed) (Ongoing)

All relevant financial relationships have been mitigated.

By completing the evaluation, you are attesting to watching the presentation in its entirety. A certificate will be immediately provided after submission.

Credits Available

AM23-TU-03-O: Biotherapies Abstract Spotlight (Enduring) Evaluation